Layout the entire industrial chain of Chinese medicine! China Traditional Chinese Medicine Acquires 51% Equity in Longzhong Pharmaceutical for 140 Million Yuan
-
Last Update: 2020-01-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
A few days ago, Chinese traditional medicine announced that the company, through its subsidiary Guangdong Yifang Pharmaceutical Co., Ltd., which holds 87.3% of the shares, signed an investment agreement with Gansu Provincial Hospital of traditional Chinese medicine, the shareholder of Gansu Longzhong Pharmaceutical Co., Ltd on December 30, 2019, and transferred 51% of the shares of Gansu Longzhong pharmaceutical held by Gansu Provincial Hospital of traditional Chinese medicine at a price of 139 million yuan According to the announcement, after the completion of equity delivery, Guangdong will hold 51% of Longzhong pharmaceutical, Gansu Provincial Hospital of traditional Chinese medicine will hold 35% of Longzhong pharmaceutical, and Gansu pharmaceutical Investment Group Co., Ltd will hold 14% of Longzhong pharmaceutical.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
